Article ; Online: COVID-19 Susceptibility in chronic obstructive pulmonary disease.
European journal of clinical investigation
2020 Volume 50, Issue 10, Page(s) e13382
Abstract: In barely nine months, the pandemic known as COVID-19 has spread over 200 countries, affecting more than 22 million people and causing over than 786 000 deaths. Elderly people and patients with previous comorbidities such as hypertension and diabetes are ...
| Abstract | In barely nine months, the pandemic known as COVID-19 has spread over 200 countries, affecting more than 22 million people and causing over than 786 000 deaths. Elderly people and patients with previous comorbidities such as hypertension and diabetes are at an increased risk to suffer a poor prognosis after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although the same could be expected from patients with chronic obstructive pulmonary disease (COPD), current epidemiological data are conflicting. This could lead to a reduction of precautionary measures in these patients, in the context of a particularly complex global health crisis. Most COPD patients have a long history of smoking or exposure to other harmful particles or gases, capable of impairing pulmonary defences even years after the absence of exposure. Moreover, COPD is characterized by an ongoing immune dysfunction, which affects both pulmonary and systemic cellular and molecular inflammatory mediators. Consequently, increased susceptibility to viral respiratory infections have been reported in COPD, often worsened by bacterial co-infections and leading to serious clinical outcomes. The present paper is an up-to-date review that discusses the available research regarding the implications of coronavirus infection in COPD. Although validation in large studies is still needed, COPD likely increases SARS-CoV-2 susceptibility and increases COVID-19 severity. Hence, specific mechanisms to monitor and assess COPD patients should be addressed in the current pandemic. |
|---|---|
| MeSH term(s) | Betacoronavirus ; Biomass ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Coronavirus Infections/physiopathology ; Disease Susceptibility ; Environmental Exposure/statistics & numerical data ; Genetic Predisposition to Disease ; Humans ; Pandemics ; Particulate Matter ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/physiopathology ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Pulmonary Disease, Chronic Obstructive/genetics ; Pulmonary Disease, Chronic Obstructive/immunology ; SARS-CoV-2 ; Severity of Illness Index ; Smoke ; Smoking/epidemiology ; Smoking/immunology |
| Chemical Substances | Particulate Matter ; Smoke |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-09-02 |
| Publishing country | England |
| Document type | Journal Article ; Review |
| ZDB-ID | 186196-7 |
| ISSN | 1365-2362 ; 0014-2972 ; 0960-135X |
| ISSN (online) | 1365-2362 |
| ISSN | 0014-2972 ; 0960-135X |
| DOI | 10.1111/eci.13382 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 677: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.